Advocacy Actions

2021-04-26 > Beijing

Conference with the Centre for International Economic and Technology Cooperation (CIETC) on Carbon Neutrality Policy and Path in China and Europe

The European Chamber co-organised the event “Carbon Neutrality Policy and Path in China and Europe” along with the Centre for International Economic and Technology Cooperation (CIETC) of the Ministry of Industry and Information Technology (MIIT) on Monday 26th April at 14:00-17:00 at European Chamber Beijing Office.

Read more
2021-04-26 > Beijing

Meeting with the Centre for Medical Device Evaluation on the Technical Guidance on the Usage of Overseas Clinical Trial Data of In Vitro Diagnostic Reagents

On 26 April, the medical device sector had a meeting with the Centre for Medical Device Evaluation on the Technical Guidance on the Usage of Overseas Clinical Trial Data of In Vitro Diagnostic Reagents.

Read more
2021-04-26 > Beijing

Lobby letter to NMPA about transition period in Administration of Cosmetics Labelling

The Cosmetics Desk submitted a lobby letter to NMPA about the transition period in Administration of Cosmetics Labelling.

Read more
2021-04-25 > Beijing

Comments to NMPA on the Administrative Measures for Medical Device Registration (Revised Draft for Comments)

On 25 April, the medical device sector sent omments to the National Medical Products Administration on the Administrative Measures for Medical Device Registration (Revised Draft for Comments).

Read more
2021-04-25 > Beijing

Comments to NMPA on the Administrative Measures for In Vitro Diagnostic Reagents Registration (Revised Draft for Comments;)

On 25 April, the medical device sector sent comments to the National Medical Products Adminstration on the Administrative Measures for In Vitro Diagnostic Reagents Registration (Revised Draft for Comments).

Read more
2021-04-25 > Beijing

Comments to NMPA on the Administration Measures for Supervision of Medical Device Manufacturing (Revised Draft for Comments)

On 25 April, the medical device sector sent comments to the National Medical Products Administrtaion on the Administration Measures for Supervision of Medical Device Manufacturing (Revised Draft for Comments).

Read more
2021-04-25 > Beijing

Comments to NMPA on the Administrative Measures for Medical Device Trading Operations (Revised Draft for Comments)

On 25 April, the medical device sector sent comments to the National Medical Products Administration on the Administrative Measures for Medical Device Trading Operations (Revised Draft for Comments).

Read more
2021-04-23 > Beijing, Shanghai, South China

Comments to the Ministry Public Security on the Road Traffic Safety Law (2021 Revised Draft for Comments)

The European Chamber submitted collated comments to the MPS on the Road Traffic Safety Law (2021 Revised Draft for Comments).

Read more
2021-04-23 > Beijing

Comments to the NHSA's National Volume Based Procurement of Joint Prostheses

The Healthcare Equipment (HCE) Working Group submitted comments to the National Healthcare Security's (NHSA's) "Concept for the National Volume Based Procurement of Joint Prostheses".

Read more
2021-04-23 > Beijing, Shanghai

AA WG Vice Chair Met with EU member States Counselors

Kevin WU, Vice Chair of AA WG was invited by the EU Delegation to join the EU monthly counselors meeting. Kevin introduce AA working group and the key advocacy plan and the WG position paper 2021-2022 to the counselors of Member States’ embassies.

Read more